Clear efficacy signals are as crucial as keeping research representative and reasonable in this complex field. Worldwide delivers studies that make sense for everyone
Whether your indication has millions of potential participants across the globe or just dozens, know that Worldwide’s dedicated team and global network of trusted partner sites can offer the expertise you need to succeed. Our extensive group of subject matter experts in both rare and common metabolic conditions help get studies done right.
EXECUTIVE DIRECTOR, PROJECT MANAGEMENT, NASH
Scott’s experience includes project management, clinical team management, portfolio development, and training across all phases of development, including compassionate use programs. He has more than 24 years of experience in the industry, with extensive NASH/NAFLD experience in Phase II and several Phase III programs. His proven leadership and strategic protocol and operational expertise ensure successful implementation and delivery for his projects.
Monika Iten, PhD, is Vice President of Project Management for Cardiovascular at Worldwide Clinical Trials. With more than 18 years of industry experience in clinical operations, performance management, and marketing, she has overseen the successful execution of large-scale, global clinical trials in cardiovascular and metabolic indications. Dr. Iten’s talent for managing complex teams has had a positive impact on team performance, leading in turn to exceptional delivery of results to our customers.
With more than 22 years of experience in the World of pharmaceuticals and research, Dr. Ziecina serves as an NAFLD/NASH scientific advisor focused on filing strategies, regulatory and safety strategies. He excels in writing protocols and drug development plans and has extensive experience in study design and medical monitoring for clinical programs.
Attila Timar-Peregrin is the Executive Director, Medical Affairs & Therapeutic Area Lead, Digestive Diseases, at Worldwide Clinical Trials. He has more than two decades of research experience as a pre-clinical and clinical researcher, study supervisor, principal investigator, chief investigator and subject matter expert for clinical studies in gastroenterology, inflammatory and rare diseases, with a special focus on gastrointestinal disorders like Inflammatory Bowel Diseases (including Crohn’s disease and ulcerative colitis), Celiac disease, Eosinophilic Esophagitis, Irritable Bowel Disease and other gastrointestinal secretory and motility disorders e.g. gastroparesis, diabetic enteropathies but also hepatic conditions including Non-Alcoholic Fatty Liver Disease, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis.
Worldwide offers broad individual and combined team experience across multiple metabolic indications. No matter the size of your study, you get a dedicated, experienced team.
Worldwide is dedicated to maximizing clinical information while minimizing patient discomfort and safety concerns. That’s why our central, bioanalytical, core imaging, and ECG laboratories offer PK/PD and biomarker tests, whole organ volume analysis (liver and spleen), hepatic fat fraction (MRI-PDFF), liver stiffness (MR elastography), SAT/VAT fat depot segmentation, and vibration controlled transient elastography (VCTE) +/- controlled attenuation parameter (CAP).
Worldwide has a large and growing global network of leading investigators, consultants, key opinion leaders, and medical experts in the fields of endocrinology and metabolic health.
Worldwide offers full-service support to metabolic studies from Phase I, starting with our co-located Clinical Pharmacology Unit and Bioanalytical lab, through post-marketing approval.
At Worldwide, we understand that our greatest strength is our personnel—our expert teams around the world that craft unparalleled design and logistics solutions for even the most challenging studies. When you start with a better CRO team, you get a better study experience for the life of your program.
Executive Director, Medical Affairs & Therapeutic Area Lead, Digestive Diseases
Executive Director, Project Management, NASH
President of CV & Evidence Business Units
Vice President Project Management, Cardiovascular
Executive Director, Scientific Solutions, Cardiovascular, Endocrine & Metabolic
Global Head of Regulatory Strategy